bionomics.com.au (NEUP): Qarzning balans kapitallashuviga nisbati
Neuphoria Therapeutics Inc. o'zining noyob modulatorlari uchun patent himoyasidan foydalangan holda markaziy nerv tizimi (CNS) bozorida raqobatlashmoqda. Potentsial daromadlar sog'liqni saqlash gigantlaridan olinadigan litsenziyalarga asoslangan, ammo operatsion defitsit va tartibga soluvchi to'siqlar sezilarli xavflarni yuzaga keltirmoqda. Kompaniyaning balans hisoboti moliyaviy leveraj ushbu bog'liqliklarni vizuallashtiradi va 0.00 ko'rsatkichi joriy qarzning kapitalga nisbati koeffitsiyentini tasdiqlaydi.
&width=1200&height=400&colorIndex=0&v=mvujvhid.si-7ayy9s0&start=20220704&end=20261030&filename=GURU_Markets_-_NEUP_-_Neuphoria-Therapeutics-Inc._-_Debt-to-Net-Assets-Ratio "NEUP: Neuphoria Therapeutics Inc. Qarzning balans kapitallashuviga nisbati 25.12.2024 - 30.10.2026 | 👁️GURU.Markets👁️")
NEUP (bionomics.com.au): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar
- aksiya narxi va konsensus maqsadli narx:
- birja kapitallashuvi ma'lumotlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning kapitalga nisbati Neuphoria Therapeutics Inc.|NEUP - Uzoq muddatli majburiyatlarning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Neuphoria Therapeutics|NEUP - Kompaniyaning jamlangan qarzlari|Qarzning balans kapitallashuviga nisbati Neuphoria Therapeutics Inc.|NEUP - Uzoq muddatli majburiyatlar|Kompaniyaning qisqa muddatli qarzlari Neuphoria Therapeutics|Tezkor likvidlik bionomics.com.au
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
Kompaniyaning fundamental tahlili:NEUP (Neuphoria)
Neuphoria Therapeutics Inc. (NEUP) uchun BNC210 loyihalarining kengayishi qarz yuklamasining qat'iy nazoratini talab qiladi. Umumiy qarzning kitob kapitalizatsiyasiga nisbati kompaniyaning o'z kapitaliga nisbatan qarz mablag'larining ulushini aks ettiradi. Ushbu ko'rsatkich umumiy majburiyatlarni sof aktivlar qiymatiga bo'lish orqali hisoblanadi. Ushbu ko'rsatkichni kamaytirish sinovlar kengaytirilgan davrda moliyaviy risklarni minimallashtiradi. Kredit yelkasini optimallashtirish neyrofarmatsevtika bozorini egallash jarayonida biznes barqarorligini ta'minlaydi.
Toʻgʻridan-toʻgʻri raqobatchilar
Biogen Inc. - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar neurocrine.com NBIX|RGC - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati AXSM (Axsome)|ACADIA Pharmaceuticals Inc (ACAD) - Qarzning balans kapitallashuviga nisbati|Balans qiymatiga qarzlar Xenon Corp (XENE)|Qarzning balans kapitallashuviga nisbati Viking Therapeutics|Qarzning balans qiymatiga nisbati SUPN (supernus.com)|Balans kapitallashuviga qarzlar CPRX|DNLI - Balans qiymatiga qarzlar|Harmony Pharma - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar Biohaven Corp BHVN|AMLX - Qarzning balans kapitallashuviga nisbati|Qarzlarning balans kapitallashuviga nisbati TRVI|PRAX: Balans kapitallashuviga qarzlar|Anavex - Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati CeriBell Corp|Balans qiymatiga qarzlar prothena.com PRTA|Qarzning balans kapitallashuviga nisbati Alector, Inc. (ALEC)|ANNX (annexonbio.com) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar OMER (Omeros)|Sof aktivlarga qarzlar Neurogene Inc (NGNE)|AC Immune Corp - Balans kapitallashuviga qarzlar|VYGR - Balans kapitallashuviga qarzlar|NMRA (Neumora Therapeutics) - Qarzning balans qiymatiga nisbati|scilexholding.com - Qarzning sof aktivlarga nisbati|Qarzning balans qiymatiga nisbati TVGN|ACOG (Alpha Cognition Corp) - Qarzning balans kapitaliga nisbati|Balans kapitallashuviga qarzlar CGTX|IKT (Inhibikase Pharma) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar SAVA (Cassava Sciences, Inc.)|Assertio Holdings (ASRT) - Balans qiymatiga qarzlar|COYA - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati VTGN (Vistagen Therapeutics)|OVID: Balans kapitallashuviga qarzlar|Acumen Pharmaceuticals, Inc (ABOS) - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati CervoMed Inc.|Alterity Therapeutics Ltd - Qarzlarning balans kapitallashuviga nisbati|Balans kapitallashuviga qarzlar CLNN|PEPG - Balans qiymatiga qarzlar|Jupiter Neurosciences Inc - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar Relmada Corp RLMD|ANVS: Qarzning balans qiymatiga nisbati|Grace Therapeutics, Inc. - Qarzning balans kapitaliga nisbati|AIFF: Balans kapitallashuviga qarzlar|KLTO - Sof aktivlarga qarzlar|NRSN (NeuroSense Therapeutics Ltd) - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati Reviva Pharmaceuticals, Inc. (RVPH)|Qarzning balans kapitallashuviga nisbati MetaVia Inc (MTVA)|Sof aktivlarga qarzlar neuraxis.com|Helius Medical Technologies - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati PASG|Minerva Neurosciences Corp - Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar Athira Pharma Corp ATHA|Addex Therapeutics (ADXN) - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati ALZN|CYCN (Cyclerion Therapeutics Inc.) - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati Protagenic (PTIX)|Qarzning balans qiymatiga nisbati KTTA (Pasithea Therapeutics)|Sof aktivlarga qarzlar cortigent.com|Qarzning balans kapitallashuviga nisbati Avenue Therapeutics ATXI|BCLI: Qarzning balans qiymatiga nisbati|Cara Therapeutics - Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar Chromocell Therapeutics Corp|ELYM (eliemtx.com) - Qarzning balans qiymatiga nisbati|Intra-Cellular Therapies, Inc. (ITCI) - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Longboard Pharmaceuticals|marinuspharma.com - Qarzlarning balans kapitallashuviga nisbati|Qarzning balans kapitallashuviga nisbati NKGen Biotech (NKGN)|NeuroBo Pharmaceuticals Inc - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar SAGE (Sage Therapeutics, Inc)|Synaptogenix, Inc (SNPX) - Balans qiymatiga qarzlar|TRVN: Qarzning balans qiymatiga nisbati|VIGL - Balans kapitallashuviga qarzlar|Anew Medical (WENA) - Qarzning balans kapitallashuviga nisbati|Cerevel Therapeutics Inc - Qarzning sof aktivlarga nisbati